Publication: Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome.
Loading...
Identifiers
Date
2018-06-26
Authors
Callejo, María
Mondejar-Parreño, Gema
Barreira, Bianca
Izquierdo-Garcia, José L
Morales-Cano, Daniel
Esquivel-Ruiz, Sergio
Moreno, Laura
Cogolludo, Ángel
Duarte, Juan
Perez-Vizcaino, Francisco
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
We have analysed whether pulmonary arterial hypertension (PAH) alters the rat faecal microbiota. Wistar rats were injected with the VEGF receptor antagonist SU5416 (20 mg/kg s.c.) and followed for 2 weeks kept in hypoxia (10% O2, PAH) or injected with vehicle and kept in normoxia (controls). Faecal samples were obtained and microbiome composition was determined by 16S rRNA gene sequencing and bioinformatic analysis. No effect of PAH on the global microbiome was found (α- or β-diversity). However, PAH-exposed rats showed gut dysbiosis as indicated by a taxonomy-based analysis. Specifically, PAH rats had a three-fold increase in Firmicutes-to-Bacteroidetes ratio. Within the Firmicutes phylum, there were no large changes in the relative abundance of the bacterial families in PAH. Among Bacteroidetes, all families were less abundant in PAH. A clear separation was observed between the control and PAH clusters based on short chain fatty acid producing bacterial genera. Moreover, acetate was reduced in the serum of PAH rats. In conclusion, faecal microbiota composition is altered as a result of PAH. This misbalanced bacterial ecosystem might in turn play a pathophysiological role in PAH by altering the immunologic, hormonal and metabolic homeostasis.
Description
MeSH Terms
Animals
Computational Biology
Gastrointestinal Microbiome
Hemodynamics
Hypertension, Pulmonary
Male
RNA, Ribosomal, 16S
Rats
Rats, Wistar
Computational Biology
Gastrointestinal Microbiome
Hemodynamics
Hypertension, Pulmonary
Male
RNA, Ribosomal, 16S
Rats
Rats, Wistar